Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 7601-7650 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05669651
Explore the Efficacy and Safety of FMT With Different Bacterial Doses in the Treatment of Hepatic Encephalopathy
NA
Active, not recruiting
100 participants
Started: Dec 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06699511
Effectiveness of Pilates in Patients With Subacute Low Back Pain
NA
Active, not recruiting
66 participants
Started: Dec 1, 2022 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT05555121
Rescue Progesterone Supplementation During Frozen Embryo Transfer
PHASE2
Active, not recruiting
150 participants
Started: Dec 1, 2022 · Completed: Jun 30, 2026
3 conditions
2 sponsors
1 location
NCT06601985
Exploring the Effect of Colonic J-pouch in Anorectal Preservation Surgery for Ultra-low Rectal Cancer.
N/A
Active, not recruiting
154 participants
Started: Dec 1, 2022 · Completed: Apr 11, 2025
5 conditions
1 sponsor
1 location
NCT04396925
Point-of-care Ultrasonography in Norwegian General Practice
N/A
Active, not recruiting
30 participants
Started: Dec 1, 2022 · Completed: Dec 31, 2024
4 conditions
2 sponsors
1 location
NCT06185361
Selective Serotonin Reuptake Inhibitors, Fluoxetine Versus the Standard Oral Desmopressin for Management of Mono-symptomatic Nocturnal Enuresis.
NA
Active, not recruiting
60 participants
Started: Dec 1, 2022 · Completed: Mar 1, 2024
3 conditions
1 sponsor
1 location
NCT05534633
APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies
NA
Active, not recruiting
407 participants
Started: Dec 1, 2022 · Completed: Mar 31, 2025
3 conditions
1 sponsor
1 location
NCT05583526
A 52-Week Study of Ritlecitinib Oral Capsules in Adults and Adolescents With Nonsegmental Vitiligo (Active and Stable) Tranquillo
PHASE3
Active, not recruiting
592 participants
Started: Dec 1, 2022 · Completed: Mar 22, 2026
2 conditions
1 sponsor
115 locations
NCT05508737
Pembrolizumab and Trifluridine/Tipiracil With Previously Treated Advanced Gastric Cancer
PHASE1/PHASE2
Active, not recruiting
75 participants
Started: Dec 1, 2022 · Completed: Dec 1, 2025
1 condition
1 sponsor
2 locations
NCT06178965
Incisional Hernia Repair by Abdominal Wall Component Release With Contemporary Onlay Mesh Fixation
NA
Active, not recruiting
17 participants
Started: Dec 1, 2022 · Completed: Jun 1, 2024
3 conditions
1 sponsor
1 location
NCT05463666
STudying Ageing in Rheumatic Diseases (STAR)
N/A
Active, not recruiting
840 participants
Started: Dec 1, 2022 · Completed: Dec 31, 2027
1 condition
2 sponsors
1 location
NCT05932940
Incidence of Descemet Membrane Detachment Post GATT by AS OCT
NA
Active, not recruiting
30 participants
Started: Dec 1, 2022 · Completed: May 10, 2024
1 condition
1 sponsor
1 location
NCT05635409
A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease
PHASE1
Active, not recruiting
8 participants
Started: Nov 30, 2022 · Completed: Nov 30, 2027
1 condition
4 sponsors
2 locations
NCT05631262
SKB264 Monotherapy in Selected Subjects with Advanced Solid Tumors
PHASE2
Active, not recruiting
321 participants
Started: Nov 30, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05524012
Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer
N/A
Active, not recruiting
40 participants
Started: Nov 30, 2022 · Completed: Sep 30, 2030
4 conditions
1 sponsor
1 location
NCT05524025
The SPOT-HPV Study
N/A
Active, not recruiting
360 participants
Started: Nov 30, 2022 · Completed: Sep 1, 2025
2 conditions
1 sponsor
2 locations
NCT05608044
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
PHASE2
Active, not recruiting
234 participants
Started: Nov 30, 2022 · Completed: Sep 30, 2029
1 condition
1 sponsor
65 locations
NCT05642962
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
PHASE1/PHASE2
Active, not recruiting
17 participants
Started: Nov 30, 2022 · Completed: Nov 30, 2025
13 conditions
1 sponsor
7 locations
NCT05719129
The Lasting Change Study
N/A
Active, not recruiting
1,445 participants
Started: Nov 30, 2022 · Completed: Dec 31, 2025
5 conditions
1 sponsor
1 location
NCT05107219
GCC Agonist Signal in the Small Intestine
PHASE1
Active, not recruiting
43 participants
Started: Nov 30, 2022 · Completed: Dec 1, 2025
3 conditions
2 sponsors
4 locations
NCT05666856
Scalable Digital Delivery of Evidence-based Training for Family to Maximize Treatment Admission Rates of Opioid Use Disorder in Loved Ones
NA
Active, not recruiting
212 participants
Started: Nov 29, 2022 · Completed: Sep 22, 2024
3 conditions
3 sponsors
1 location
NCT05688280
Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS
PHASE1/PHASE2
Active, not recruiting
42 participants
Started: Nov 29, 2022 · Completed: Feb 28, 2025
4 conditions
1 sponsor
16 locations
NCT05278234
STEPS: An Efficacy Trial of a Chronic Pain Self-Management Program for Older Adults
NA
Active, not recruiting
414 participants
Started: Nov 29, 2022 · Completed: Apr 1, 2026
1 condition
3 sponsors
1 location
NCT05458622
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol
PHASE3
Active, not recruiting
25 participants
Started: Nov 29, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
1 location
NCT05549219
24-Week Study to Assess the PD, Safety, Tolerability, and PK of GLM101 in Participants With PMM2-CDG
PHASE2
Active, not recruiting
44 participants
Started: Nov 29, 2022 · Completed: Nov 30, 2025
2 conditions
1 sponsor
4 locations
NCT05729620
Evaluation of STARgraft-3 for Hemodialysis
NA
Active, not recruiting
21 participants
Started: Nov 29, 2022 · Completed: Jul 31, 2024
1 condition
1 sponsor
1 location
NCT05617755
AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer
PHASE1
Active, not recruiting
19 participants
Started: Nov 29, 2022 · Completed: Feb 28, 2027
9 conditions
1 sponsor
8 locations
NCT05900999
Addressing Arm Non-use by Encouraging Idle-time Activity During Early Recovery from Stroke
NA
Active, not recruiting
36 participants
Started: Nov 29, 2022 · Completed: Jun 30, 2025
2 conditions
2 sponsors
1 location
NCT05645146
Enhancing Long-Term Smoking Abstinence Among Cervical Cancer Survivors (Project ACCESS)
NA
Active, not recruiting
360 participants
Started: Nov 29, 2022 · Completed: Jan 31, 2028
3 conditions
2 sponsors
1 location
NCT05545150
Volumetric Specimen Imager Device for the Intraoperative Imaging of Patients With Breast Carcinoma and Breast Ductal Carcinoma In Situ, The VIVID Study
PHASE2
Active, not recruiting
113 participants
Started: Nov 28, 2022 · Completed: Jul 1, 2026
6 conditions
2 sponsors
4 locations
NCT05565417
Study of the Monoclonal Antibody IMT-009 in Patients With Advanced Solid Tumors or Lymphomas
PHASE1/PHASE2
Active, not recruiting
67 participants
Started: Nov 28, 2022 · Completed: Jan 31, 2026
12 conditions
1 sponsor
9 locations
NCT05659914
Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
PHASE2
Active, not recruiting
40 participants
Started: Nov 28, 2022 · Completed: Jun 1, 2026
1 condition
2 sponsors
3 locations
NCT05629585
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03)
PHASE3
Active, not recruiting
1,174 participants
Started: Nov 28, 2022 · Completed: Jan 30, 2030
1 condition
3 sponsors
276 locations
NCT05629065
Pathways to Advance Targeted and Helpful Serious Illness Conversations (PATH-SIC)
NA
Active, not recruiting
800 participants
Started: Nov 28, 2022 · Completed: Jun 30, 2028
5 conditions
1 sponsor
1 location
NCT04945681
Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People
PHASE4
Active, not recruiting
2,882 participants
Started: Nov 27, 2022 · Completed: Feb 28, 2026
1 condition
4 sponsors
1 location
NCT05552092
Optimal Depth for Esophageal Stethoscope
NA
Active, not recruiting
40 participants
Started: Nov 26, 2022 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT05569811
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial
PHASE2
Active, not recruiting
120 participants
Started: Nov 25, 2022 · Completed: Jul 31, 2030
1 condition
2 sponsors
25 locations
NCT05657054
Exercise Intervention Targeting Hip Strengthening Compared to Usual Care in Patients Undergoing Revision Hip Replacement
NA
Active, not recruiting
84 participants
Started: Nov 25, 2022 · Completed: Dec 1, 2027
1 condition
9 sponsors
9 locations
NCT05476887
To Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of KP104
PHASE2
Active, not recruiting
35 participants
Started: Nov 25, 2022 · Completed: Feb 28, 2025
1 condition
1 sponsor
4 locations
NCT05229263
Multiparametric MRI in Healthy Volunteers and CKD Patients
NA
Active, not recruiting
140 participants
Started: Nov 25, 2022 · Completed: Dec 31, 2025
2 conditions
4 sponsors
4 locations
NCT05598853
Intrathecal Double Checkpoint Inhibition
PHASE1
Active, not recruiting
26 participants
Started: Nov 25, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
3 locations
NCT05640193
A Study of LN-144 in People With Metastatic Melanoma to the Brain
PHASE1
Active, not recruiting
10 participants
Started: Nov 25, 2022 · Completed: Nov 30, 2026
1 condition
3 sponsors
1 location
NCT05693558
NVD-003 in the Treatment of Congenital Pseudarthrosis of the Tibia
PHASE1
Active, not recruiting
4 participants
Started: Nov 24, 2022 · Completed: Jan 31, 2026
1 condition
1 sponsor
2 locations
NCT06553404
Myoslow Lens Study to Control Myopia in Children
PHASE4
Active, not recruiting
125 participants
Started: Nov 24, 2022 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT05781958
Cadonilimab Combined With Gem/Cis as First Line Therapy in Patients With Advanced ICC
PHASE2
Active, not recruiting
64 participants
Started: Nov 24, 2022 · Completed: Dec 1, 2024
1 condition
1 sponsor
1 location
NCT05754983
Risk Factors and Long-term Impact of ICIs
N/A
Active, not recruiting
1,000 participants
Started: Nov 24, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05344066
Manchester Intermittent Diet in Gestational Diabetes Acceptability Study
NA
Active, not recruiting
26 participants
Started: Nov 24, 2022 · Completed: Jul 31, 2024
6 conditions
3 sponsors
1 location
NCT06614140
Personalized Neoantigen Cancer Vaccine for Patients with Solid Tumors
PHASE1/PHASE2
Active, not recruiting
8 participants
Started: Nov 24, 2022 · Completed: Aug 15, 2025
2 conditions
1 sponsor
1 location
NCT05146375
Genes Modulating the Severity of Aortic Aneurysms (MSF1-TGFBR2)
N/A
Active, not recruiting
17 participants
Started: Nov 24, 2022 · Completed: Nov 30, 2025
1 condition
3 sponsors
1 location
NCT05623592
Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis
PHASE2
Active, not recruiting
52 participants
Started: Nov 23, 2022 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
Previous
1
More pages
150
151
152
153
154
155
156
More pages
431
Next